Although the ban on funding embryonic stem cells was recently lifted by President Barack Obama, the controversy over this research still remains.New types of pluripotent stem cells have recently emerged as alternatives to embryonic stem cells. These include induced pluripotent stem cells (IPS cells) and parthenogenic stem cells. In this episode of BioTalk, Kent Vrana (1:25) , Ph.D., chair of the department of Pharmacology at Penn State University College of Medicine, and Ken Aldrich (21:55), CEO of International Stem Cell Corporation, discuss the current state of stem cell research.
Behind the Scenes of GE's Cell Imaging Contest | BenchTalk, Episode 13
The Rise in Droplet PCR | BenchTalk, Episode 12
AGBT13 Round-Up: Advances in Genome Biology and Technology | BenchTalk, Episode 11 New York, NY
Cell Culture: Why Does It Remain Difficult? | BenchTalk, Episode 10 New York, NY
Cancer Stem Cells | BenchTalk, Episode 9 New York, NY
Optogenetics: Shining a Light on Neuroscience | BenchTalk, Episode 8 New York, NY